RCEL241115P20000
- 0.00
- 0.000.00%
Avita Medical Newsroom
Express News | AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand
Avita Medical's Total Revenue Climbs 44% in Q3; Net Loss Widens
Avita Medical Target Price Raised 28% to A$4.60/Share by Bell Potter>AVH.AU
AVITA Medical, Inc. (RCEL) Q3 2024 Earnings Call Transcript
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Cuts Target Price to $20
AVITA Medical to Host Investor Webinar Briefing
Express News | Piper Sandler Reiterates Neutral on AVITA Medical, Raises Price Target to $12
AVITA Medical Analyst Ratings
Avita Medical: Strong Buy Rating Backed by Record Sales and Promising Growth Prospects
Express News | Avita Medical Shares Are Trading Higher After the Company Issued Q4 Revenue Guidance Above Estimates
Express News | Corrected-AVITA Medical Inc - Q3 Commercial Revenue of $19.5 Mln (Corrects Currency to USD)
10-Q: Q3 2024 Earnings Report
Express News | AVITA Medical Sees Q4 2024 Revenue $22.3M-$24.3M Vs $19.425M Est
Express News | AVITA Medical Q3 2024 GAAP EPS $(0.62) Misses $(0.44) Estimate, Sales $19.39M Miss $19.43M Estimate
Express News | AVITA Medical Q3 Operating Expenses USD 30.2 Million
Here Are the Major Earnings After the Close Today
Earnings Preview: RCEL to Report Financial Results Post-market on November 07
AVITA Medical to Announce Third Quarter 2024 Financial Results
AVITA Medical (NASDAQ:RCEL) Shareholders Have Endured a 74% Loss From Investing in the Stock Five Years Ago
Buy These Small Cap ASX Shares Before Interest Rates Fall